Revvity EBITDA 2010-2024 | RVTY

Revvity annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Revvity EBITDA for the quarter ending September 30, 2024 was $0.207B, a 15.54% increase year-over-year.
  • Revvity EBITDA for the twelve months ending September 30, 2024 was $0.740B, a 7.32% decline year-over-year.
  • Revvity 2023 annual EBITDA was $0.74B, a 39.48% decline from 2022.
  • Revvity 2022 annual EBITDA was $1.222B, a 24.08% decline from 2021.
  • Revvity 2021 annual EBITDA was $1.61B, a 49.89% increase from 2020.
Revvity Annual EBITDA
(Millions of US $)
2023 $740
2022 $1,222
2021 $1,610
2020 $1,074
2019 $601
2018 $527
2017 $409
2016 $397
2015 $365
2014 $279
2013 $361
2012 $237
2011 $212
2010 $249
2009 $200
Revvity Quarterly EBITDA
(Millions of US $)
2024-09-30 $207
2024-06-30 $195
2024-03-31 $154
2023-12-31 $184
2023-09-30 $179
2023-06-30 $189
2023-03-31 $187
2022-12-31 $243
2022-09-30 $229
2022-06-30 $360
2022-03-31 $390
2021-12-31 $399
2021-09-30 $258
2021-06-30 $411
2021-03-31 $542
2020-12-31 $419
2020-09-30 $312
2020-06-30 $236
2020-03-31 $107
2019-12-31 $205
2019-09-30 $141
2019-06-30 $151
2019-03-31 $105
2018-12-31 $165
2018-09-30 $126
2018-06-30 $142
2018-03-31 $94
2017-12-31 $126
2017-09-30 $105
2017-06-30 $102
2017-03-31 $77
2016-12-31 $118
2016-09-30 $101
2016-06-30 $92
2016-03-31 $86
2015-12-31 $72
2015-09-30 $104
2015-06-30 $98
2015-03-31 $91
2014-12-31 $11
2014-09-30 $88
2014-06-30 $99
2014-03-31 $81
2013-12-31 $129
2013-09-30 $92
2013-06-30 $73
2013-03-31 $67
2012-12-31 $5
2012-09-30 $75
2012-06-30 $83
2012-03-31 $74
2011-12-31 $14
2011-09-30 $65
2011-06-30 $67
2011-03-31 $66
2010-12-31 $76
2010-09-30 $65
2010-06-30 $57
2010-03-31 $51
2009-12-31 $55
2009-09-30 $36
2009-06-30 $61
2009-03-31 $48
Sector Industry Market Cap Revenue
Medical Medical Services $13.453B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00